Exchange: NASDAQ·Updated 07:58 PM EST
GUTS logo

GUTS Fractyl Health Inc.

$0.82
$0.1353
(14.16%)
Today
Closed $0.82
$0.0198
(2.42%)
After Hours
Reported EarningsNov 12
Mkt Cap$10.88M
Vol337,175.00

About GUTS

Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
54

Neutral Sentiment

How do you feel about GUTS?

Ritschier
$GUTS Mr. CEO is back on X/Twitter, well, sort of. But he's kinda right. It's not just the weight maintenance numbers, it's the why behind it. Stop a GLP-1 and the weight comes back within weeks – stop it after Revita and it's different (proven already). If a big company bought this, the first study to fund: biopsies at 6–12 months comparing stem cells and nutrient transporters against sham patients. The working theory: years of overeating reprogramme the duodenal lining to absorb more and push the body towards storing. Only Revita wipes that layer, and it grows back in an actual post-diet state (the GLP-1 'diet' doesn't seem to provide that) – which holds until you flood it again. If that's proven, the GLP-1 comparison would matter a lot less: it's a reset vs. a suppressant. At best, you'd own an adjunct therapy no drug can offer (for the foreseeable future). Yeah, a bit of fantasy time here. But glad to see the CEO hasn't given up yet :)
1
4
Ritschier
$GUTS If the macro picture brightens and the 12-month data comes in on par with the midpoint (which seems likely enough, since the two are running parallel so far), bankruptcy doesn’t look like the most plausible outcome. The CEO will grind this out. Or somebody will see the merit in it, as before – again, the data hasn’t changed. If macro stays the same and the >14 cm group somehow doesn’t deliver midpoint-like results, then yes, things might go south fast(er). I’d combine the two factors (good+good, good+bad, bad+good, bad+bad) and argue the combinations lead to different outcomes here. People really seem to overweight their read of the data – and underestimate how (NOT) keen capital is on microcaps right now.
4
TraderBuckNKY
$GUTS BURLINGTON, Mass. , Oct. 29, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl ), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced findings from company-sponsored market research highlighting strong patient interest in a one-time procedural approach to weight maintenance following GLP-1 therapy. The findings reinforce the commercial opportunity for investigational Revita. Fractyl estimates that approx. 1 million patients each month in the United States face the challenge of weight regain following discontinuation. 65% of those taking a GLP-1 for weight loss (without type 2 diabetes) stop within one year, and only about 1 in 12 people prescribed a GLP-1 for obesity are still on it after three years [1,2]. Revita is being developed to address this post-GLP-1 weight maintenance need.
3
Ritschier
$GUTS There’s always a chance. E.g., a glitch in the matrix or a happier humanity in a parallel universe. You name it. But... for GUTS? Well... 1) Some good news on the listing situation would help the stock a lot. 2) BSX (a bit busy right now...) or another strategic, plus some financier, could throw some money in, help get it to market and buy it at some point. 3) Solid 12-month data the market takes well. (I doubt it.) 4) The market realizes that, as great as GLP-1s are, they are not the final answer for everyone suffering from obesity – and Revita slips into that space between surgery and drugs as an option that might work well enough for a critical mass of patients.
3
Somewhereman
$GUTS headed for bankruptcy...since raising money via dilution is now practically off the table...sad to see.
1
TWITLIEDETECTOR
$GUTS this stock is ready to collapse. they will try and keep it over a $1 but i doubt it. could be a good buy if it crashes and they sell the company
2
SankaYield
$GUTS a theory around big IPO like $ANT will suck up all free liquidity in the market for a couple days. Let's see if the volume drops as retail traders try for Anthropic. If there is still volume it could mean institutional investors are building positions. Also heightened risk of price drop if propped up by retail as retail traders might sell their shares so they can trade the ipo event.
1
MUFDVR
$GUTS Biorich bot says hello from his new baby bashing job at SLS where it's dead wrong once again. The mayor. Hahahahaha. Shouldn't have listened to the idiot here. We don't over there it's a total clown.
1
ReversalRuler
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $GUTS $CMND $ZCMD $MYPS ,,
1
Jorlev
$GUTS Fractyl Health (GUTS) reported quarterly losses of $(1.07) per share which beat the analyst consensus estimate of $(1.51) by 29.14 percent. This is a 87.44 percent increase over losses of $(8.52) per share from the same period last year.
1
JPine26
$GUTS if you look close enough this evening and look at the moon, you can see a new crater created by $GUTS
1
Golferhack12
$GUTS this stock just had a reverse split a couple of weeks ago and now they're already under a dollar
1
Ked1977
$GUTS keep a list of board member and executive names. If you see them in a board or hired by another company- RUN.
1
TWITLIEDETECTOR
$GUTS i’m going to maybe buy in if it crashes back to .50 cents. seems like an acquisition play. where’s biobich?
1
Ked1977
$GUTS The CEO who torched GUTS has lined himself up for another title while throwing 45% of the workforce out the door—as if gutting the company could hide his own failures. Investors weren’t fooled. The reverse split failed, Nasdaq still hasn’t confirmed compliance, and the stock is headed back under $1 and toward delisting. He’s also personally named in a shareholder lawsuit over alleged misleading statements. If he’s forced to pay for this wreckage out of his absurd compensation, that’s the only poetic justice this disaster deserves.
1
TWITLIEDETECTOR
$GUTS maybe biobich is helping all the employees at GUTS find new jobs. nobody posted about the huge layoff
1
Penny0001
$GUTS so if submission for authorization is December 2026 and authorization may not be until late 2027 and they only have enough money until q2 2027, seems like they will need some financing before this may be authorized. Not clear how they will make to that date without additional financing unless this is authorized significantly sooner?
StocktwitsEarnings
$GUTS Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.07 up 87.35% YoY • Fractyl Health expects quarterly operating cash spending to be reduced by approximately 50%, to approximately $8M, by the end of the second quarter of 2027.
SankaYield
$GUTS for the Robinhood Q&A, I think you can only comment if you own shares since the box is greyed out for me
inmarketswetrust
$GUTS there’s no alternative for folks who take GLP1s, lose some weight and want to get off the drugs. So does that mean everyone is stuck on GLP1s forever? Let’s be honest, how did people get so fat? Movies from 1950’s/1960’s: everyone was thin. So must be diet, plus screen time, sedentary lifestyle, etc. This problem may be unsolvable because unless a person is willing to make dietary and exercise changes and eat that Mediterranean plant forward fish and chicken diet and move their body, worri d that America stays fat or they all stay on GLP1s. Waiting for more time to go by to see if there are other health consequences not yet identified from GLP1s- obviously sarcopenia/osteoporosis are side effects, especially for older users. Just don’t see an off ramp for GLP1s- was hoping GUTS procedure would be it…..

Advertisement|Remove ads.